RF
+
Exosome cross section illustration
RF
+
Exosome cross section illustration
RF
+
Epidermal growth factor receptor illustration
RF
+
Epidermal growth factor and receptor complex illustration
RF
+
Epidermal growth factor and receptor complex illustration
RF
+
Epidermal growth factor molecules illustration
RM
+
EGFR Receptor inactivated by Afatinib illustration
RM
+
Illustration of the dimer of the intracellular domain of the epidermal growth factor receptor (EGFR) which contains a tyrosine kinase (blue) The kin
RM
+
Osimertinib anti-cancer drug
RM
+
Osimertinib anti-cancer drug
RM
+
Osimertinib anti-cancer drug
RM
+
Osimertinib anti-cancer drug
RM
+
Osimertinib anti-cancer drug
RF
+
Poziotinib cancer drug molecule illustration
RF
+
Dacomitinib cancer drug molecule illustration
RM
+
Cetuximab Erbitux anti cancer drug PLM
RM
+
Cetuximab chemotherapy drug molecule Computer illustration showing the structure of a molecule of the chemotherapy drug cetuximab This drug markete
RM
+
Epidermal growth factor and receptor complex illustration
RM
+
Chinese hamster ovary (CHO) cell scanning electron micrograph (SEM) Chinese hamster ovary (CHO) cells are a cell line derived from the ovary of the
RM
+
Epidermal growth factor receptor complex
RM
+
Epidermal growth factor receptor complex Computer model showing the structure of an epidermal growth factor receptor kinase domain (blue-grey cyan)
RM
+
Chinese hamster ovary (CHO) cell coloured scanning electron micrograph (SEM) Chinese hamster ovary (CHO) cells are a cell line derived from the ovar
RM
+
Chinese hamster ovary (CHO) cell coloured scanning electron micrograph (SEM) Chinese hamster ovary (CHO) cells are a cell line derived from the ovar
RM
+
Chinese hamster ovary cell SEM
RM
+
Chinese hamster ovary cell SEM
RM
+
Cetuximab Molecular model of the drug cetuximab This monoclonal antibody sold under the brand name Erbitux is an epidermal growth factor receptor
RM
+
Osimertinib lung cancer drug molecule
RM
+
Osimertinib lung cancer drug molecule Computer model showing the structure of a molecule of the epidermal growth factor receptor (EGFR) tyrosine kina
RM
+
Gefitinib Molecular model of the chemotherapy drug gefitinib (C22H24ClFN4O3) used in the treatment of certain breast lung and other cancers I
RM
+
Cancer drug attacking cancer cells 3D computer illustration of the monoclonal antibody drug cetuximab (orange) attacking cancer cells (round) Cetuxi
RM
+
Cancer drug attacking cancer cells
RM
+
Cancer drug attacking cancer cells 3D computer illustration of the monoclonal antibody drug cetuximab (orange) attacking cancer cells (round) Cetuxi
RM
+
Cancer drug attacking cancer cells
RM
+
Cetuximab chemotherapy drug 3D computer illustration showing the structure of a molecule of the chemotherapy drug cetuximab This drug marketed as E
RM
+
Cetuximab chemotherapy drug 3D computer illustration showing the structure of a molecule of the chemotherapy drug cetuximab This drug marketed as E
RM
+
Cancer drug attacking cancer cells 3D computer illustration of the monoclonal antibody drug cetuximab (orange) attacking cancer cells (round) Cetuxi
RM
+
Cancer treatment Illustration of the monoclonal antibody drug Cetuximab (orange) attacking cancer cells (purple) Cetuximab is a chemotherapy drug u
RM
+
Monoclonal antibody fragment
RM
+
Monoclonal antibody fragment Molecular model of the antigen-binding fragment (Fab) of the monoclonal antibody cetuximab Cetuximab is a chemotherapy
RM
+
Epidermal growth factor Molecular model of human epidermal growth factor (EGF green) complexed with its receptor (pink) EGF plays an important role
RM
+
Epidermal growth factor Molecular model of human epidermal growth factor (EGF green) complexed with its receptor (pink) EGF plays an important role
RM
+
Cetuximab chemotherapy drug being prepared This drug marketed as Erbitux is used to treat metastatic colorectal cancer head and neck cancers It i
RM
+
Cetuximab chemotherapy drug
RF
+
Gefitinib drug molecule
RF
+
Gefitinib Molecular model of the chemotherapy drug gefitinib (C22H24ClFN4O3) used in the treatment of certain breast lung and other cancers I
RF
+
Vandetanib cancer drug molecule (kinase inhibitor) Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles hydrogen (
RF
+
Lapatinib cancer drug molecule
RF
+
Gefinitib cancer drug molecule Inhibitor of the epidermal growth factor receptor (EGFR) Stylized skeletal formula (chemical structure) Atoms are sh
RF
+
Erlotinib cancer drug molecule
RF
+
Gefinitib cancer drug molecule
RF
+
Gefinitib cancer drug molecule Inhibitor of the epidermal growth factor receptor (EGFR) Atoms are represented as spheres with conventional colour co
RF
+
Gefinitib cancer drug molecule Inhibitor of the epidermal growth factor receptor (EGFR) Atoms are represented as spheres with conventional colour co
RF
+
Gefinitib cancer drug molecule Inhibitor of the epidermal growth factor receptor (EGFR) Atoms are represented as spheres with conventional colour co
RF
+
Erlotinib cancer drug chemical structure Atoms are represented as spheres with conventional color coding hydrogen (white) carbon (black) nitrogen
RF
+
Brigatinib cancer drug molecule White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Brigatinib cancer drug molecule Stylized skeletal formula (chemical structure) atoms are shown as color-coded circles with thick black outlines and
RF
+
Brigatinib cancer drug molecule Stylized skeletal formula (chemical structure) atoms are shown as color-coded circles connected by thin bonds on a
RF
+
Brigatinib cancer drug molecule Blue skeletal formula on white background
RF
+
Vandetanib cancer drug molecule (kinase inhibitor) Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles with thick
RF
+
Vandetanib cancer drug molecule (kinase inhibitor) White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Vandetanib cancer drug molecule (kinase inhibitor) Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles connected b
RF
+
Vandetanib cancer drug molecule (kinase inhibitor) Blue skeletal formula on white background
RF
+
Osimertinib cancer drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles with thick black outlines and
RF
+
Osimertinib cancer drug molecule White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Osimertinib cancer drug molecule illustration
RF
+
Osimertinib cancer drug molecule Blue skeletal formula on white background
RF
+
Neratinib breast cancer drug molecule Stylized skeletal formula (chemical structure) atoms are shown as color-coded circles with thick black outline
RF
+
Neratinib breast cancer drug molecule White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Neratinib breast cancer drug molecule Stylized skeletal formula (chemical structure) atoms are shown as color-coded circles connected by thin bonds
RF
+
Neratinib breast cancer drug molecule Blue skeletal formula on white background
RM
+
Cancer drug attacking cancer cells
RM
+
Cancer drug attacking cancer cells illustration
RM
+
Cancer drug attacking cancer cells illustration
RM
+
Poziotinib cancer drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles with thick black outlines and
RM
+
Poziotinib cancer drug molecule White skeletal formula on dark teal gradient background with hexagonal pattern MOLEKUULSCIENCE PHOTO LIBRARY
RM
+
Poziotinib cancer drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles connected by thin bonds on a
RM
+
Poziotinib cancer drug molecule Blue skeletal formula on white background MOLEKUULSCIENCE PHOTO LIBRARY
RM
+
Dacomitinib cancer drug molecule (EGFR inhibitor) Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles with thick b
RM
+
Dacomitinib cancer drug molecule (EGFR inhibitor) White skeletal formula on dark teal gradient background with hexagonal pattern MOLEKUULSCIENCE P
RM
+
Dacomitinib cancer drug molecule
RM
+
Dacomitinib cancer drug molecule
RF
+
Epidermal growth factor molecule
RF
+
Epidermal growth factor (EGF) signalling protein molecule Stylized combination of a semi-transparent surface model with a cartoon representation Car
RF
+
Epidermal growth factor molecule
RF
+
Epidermal growth factor (EGF) signalling protein molecule Cartoon model secondary structure colouring (helices blue)
RF
+
Epidermal growth factor (EGF) signalling protein molecule Cartoon model secondary structure colouring (helices blue)
RF
+
Epidermal growth factor (EGF) signalling protein molecule Ball-and-stick model with conventional colour coding
RF
+
Epidermal growth factor molecule
RF
+
Vandetanib cancer drug molecule (kinase inhibitor) Atoms are represented as spheres and are colour coded hydrogen (white) carbon (grey) oxygen (re
RF
+
Vandetanib cancer drug molecule (kinase inhibitor) Atoms are represented as spheres and are colour coded hydrogen (white) carbon (grey) oxygen (re
RF
+
Vandetanib cancer drug molecule (kinase inhibitor) Atoms are represented as spheres and are colour coded hydrogen (white) carbon (black) oxygen (r
92
0
https://www.afloimages.com/search/egfr.html